Why 23andMe Is Betting Big On An Open Science Model
Jakson tiedot
Jakson kuvaus
On this episode oof Iconoclast, 23andMe CEO and Founder Anne Wojcicki sits down with Forbes to discuss 23andMe’s transformation from a public direct-to-consumer genetic testing company into a nonprofit research institute focused on preventative health. Wojcicki also discusses her personal family history with healthcare advocacy, the lessons she learned from navigating a complex public market corporate restructuring, and the company's citizen-powered open science platform. Read the full story on Forbes: https://www.forbes.com/sites/maneetahuja/2026/06/18/iconoclast-podcast/ Subscribe to FORBES: https://www.youtube.com/user/Forbes?sub_confirmation=1 Fuel your success with Forbes. Gain unlimited access to premium journalism, including breaking news, groundbreaking in-depth reported stories, daily digests and more. Plus, members get a front-row seat at members-only events with leading thinkers and doers, access to premium video that can help you get ahead, an ad-light experience, early access to select products including NFT drops and more: https://account.forbes.com/membership/?utm_source=youtube&utm_medium=display&utm_campaign=growth_non-sub_paid_subscribe_ytdescript Stay Connected Forbes newsletters: https://newsletters.editorial.forbes.com Forbes on Facebook: http://fb.com/forbes Forbes Video on Twitter: http://www.twitter.com/forbes Forbes Video on Instagram: http://instagram.com/forbes More From Forbes: http://forbes.com Forbes covers the intersection of entrepreneurship, wealth, technology, business and lifestyle with a focus on people and success.